Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 16, 2025, AnaptysBio (ANAB) has a market cap of $0.56 billion USD. According to our data, AnaptysBio is ranked No.5829 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 16, 2025 | $0.56 B |
37.78%
|
| Dec 31, 2024 | $0.40 B |
-38.19%
|
| Dec 29, 2023 | $0.65 B |
-30.88%
|
| Dec 30, 2022 | $0.94 B |
-10.82%
|
| Dec 31, 2021 | $1.06 B |
61.63%
|
| Dec 31, 2020 | $0.65 B |
32.31%
|
| Dec 31, 2019 | $0.49 B |
-74.53%
|
| Dec 31, 2018 | $1.94 B |
-36.67%
|
| Dec 29, 2017 | $3.06 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Regeneron Pharmaceuticals
REGN
|
$60.99 B |
1.014 B
|
USA
|
 Amgen
AMGN
|
$158.77 B |
0.132 B
|
USA
|
 Biogen
BIIB
|
$17.12 B |
0.000 M
|
USA
|
 Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
USA
|
 Vertex Pharmaceuticals
VRTX
|
$128.67 B |
-0.003 M
|
USA
|
 Incyte
INCY
|
$11.31 B |
0.000 M
|
USA
|
 Sarepta Therapeutics
SRPT
|
$5.28 B |
-0.000 M
|
USA
|
 Alnylam Pharmaceuticals
ALNY
|
$29.89 B |
-0.001 M
|
USA
|
 BioMarin Pharmaceutical
BMRN
|
$11.51 B |
-0.000 M
|
USA
|
 Ionis Pharmaceuticals
IONS
|
$4.51 B |
0.000 M
|
USA
|
 Moderna
MRNA
|
$10.14 B |
-0.001 M
|
USA
|
 Novavax
NVAX
|
$1.03 B |
0.000 M
|
USA
|
 Sangamo Therapeutics
SGMO
|
$0.17 B |
0.000 M
|
USA
|
 Ultragenyx
RARE
|
$3.32 B |
0.000 M
|
USA
|
| Market Cap | = | ANAB Stock Price | * | ANAB Shares Outstanding |
| = | $18.10 | * | 30.67 M | |
| = | $0.56 B |